Top Markets
Coin of the day
Proteonomix, Inc. Proteonomix, Inc.

Proteonomix, Inc.

PROT
Clasificación en acciones #42572
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics... Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$791.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Proteonomix, Inc. (PROT)

Categoría

Ratio P/S de Proteonomix, Inc. (PROT)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Proteonomix, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Proteonomix, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR